These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

909 related articles for article (PubMed ID: 25132759)

  • 41. Gastric cardia adenocarcinoma microRNA profiling in Chinese patients.
    Gao S; Zhou F; Zhao C; Ma Z; Jia R; Liang S; Zhang M; Zhu X; Zhang P; Wang L; Su F; Zhao J; Liu G; Peng B; Feng X
    Tumour Biol; 2016 Jul; 37(7):9411-22. PubMed ID: 26781873
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis.
    Huang T; Zhou Y; Zhang J; Wong CC; Li W; Kwan JSH; Yang R; Chan AKY; Dong Y; Wu F; Zhang B; Cheung AHK; Wu WKK; Cheng ASL; Yu J; Wong N; Kang W; To KF
    Oncogene; 2018 Mar; 37(9):1159-1174. PubMed ID: 29234151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells.
    Jin W; Han H; Liu D
    Cancer Biomark; 2019; 26(2):183-191. PubMed ID: 31403943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oncogenic miR-544 is an important molecular target in gastric cancer.
    Zhi Q; Guo X; Guo L; Zhang R; Jiang J; Ji J; Zhang J; Zhang J; Chen X; Cai Q; Li J; Liu B; Zhu Z; Yu Y
    Anticancer Agents Med Chem; 2013 Feb; 13(2):270-5. PubMed ID: 22934698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
    Humphries B; Yang C
    Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer.
    Shin JY; Kim YI; Cho SJ; Lee MK; Kook MC; Lee JH; Lee SS; Ashktorab H; Smoot DT; Ryu KW; Kim YW; Choi IJ
    PLoS One; 2014; 9(1):e85205. PubMed ID: 24465504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
    Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
    Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of microRNAs in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer.
    Pandey M; Mukhopadhyay A; Sharawat SK; Kumar S
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188552. PubMed ID: 33892053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer.
    Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z
    J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer.
    Mu YP; Sun WJ; Lu CW; Su XL
    Asian Pac J Cancer Prev; 2015; 16(12):4813-20. PubMed ID: 26163596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent advances of miRNAs in the development and clinical application of gastric cancer.
    Wu SR; Wu Q; Shi YQ
    Chin Med J (Engl); 2020 Aug; 133(15):1856-1867. PubMed ID: 32649523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Upgrading the Repertoire of miRNAs in Gastric Adenocarcinoma to Provide a New Resource for Biomarker Discovery.
    Pewarchuk ME; Barros-Filho MC; Minatel BC; Cohn DE; Guisier F; Sage AP; Marshall EA; Stewart GL; Rock LD; Garnis C; Lam WL
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNAs in gastric cancer: from benchtop to bedside.
    Tong F; Cao P; Yin Y; Xia S; Lai R; Liu S
    Dig Dis Sci; 2014 Jan; 59(1):24-30. PubMed ID: 24114043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A.
    Shrestha S; Yang CD; Hong HC; Chou CH; Tai CS; Chiew MY; Chen WL; Weng SL; Chen CC; Chang YA; Lee ML; Huang WY; Hsu SD; Chen YC; Huang HD
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283424
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Shao Q; Xu J; Guan X; Zhou B; Wei W; Deng R; Li D; Xu X; Zhu H
    Int J Med Sci; 2018; 15(1):86-94. PubMed ID: 29333091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer.
    Tsai KW; Hu LY; Chen TW; Li SC; Ho MR; Yu SY; Tu YT; Chen WS; Lam HC
    Oncol Rep; 2015 Jan; 33(1):485-93. PubMed ID: 25394359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-216b regulates cell proliferation, invasion and cycle progression via interaction with cyclin T2 in gastric cancer.
    Chen X; Zhang L; Song Q; Chen Z
    Anticancer Drugs; 2020 Jul; 31(6):623-631. PubMed ID: 32058347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation.
    Wu C; Zheng X; Li X; Fesler A; Hu W; Chen L; Xu B; Wang Q; Tong A; Burke S; Ju J; Jiang J
    Oncotarget; 2016 Mar; 7(12):14522-36. PubMed ID: 26894855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of downregulated circRNAs from tissue and plasma of patients with gastric cancer and construction of a circRNA-miRNA-mRNA network.
    Liu J; Li Z; Teng W; Ye X
    J Cell Biochem; 2020 Nov; 121(11):4590-4600. PubMed ID: 32052496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.